Table 2. Induction of DNA sequence alterations at targeted loci.
Targeted locus | Amount TALEN RNA injected | # embryos | # (%) embryos with mutations |
golden [exon 2] | Uninjected | 7 | 0 (0%) |
100 pg | 42 | 42 (100%) | |
ryr3 [exon 5] | Uninjected | 16 | 0 (0%) |
100 pg | 47 | 46 (97.9%) | |
tbx6 [exon 3] | Uninjected | 25 | 0 (0%) |
100 pg | 54 | 54 (100%) | |
ryr1a [exon 6] | Uninjected | 24 | 0 (0%) |
100 pg | 24 | 24 (100%) |
One cell stage embryos were injected with TALEN mRNAs as indicated. gDNA from individual 1–2 dpf embryos was analyzed by HRMA for sequence alterations at targeted loci.